Evidence map›Paper›PMID 40898196›Full record

ArticleBMC pulmonary medicine2025

Risk factors for severe COVID-19 and development of a predictive model.

Ling Zhang, Xinran Li, Ziyan Wang, Lei Zhao, Huixia Gao, Conghui Liu, Jing Bai, Tiejun Liu, Weibin Chen, Wenqiang Li and 3 more

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ling ZhangNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Xinran LiNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Ziyan WangNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Lei ZhaoThe Fifth Hospital, Shijiazhuang, Hebei Province, China.
Huixia GaoThe Fifth Hospital, Shijiazhuang, Hebei Province, China.
Conghui LiuNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Jing BaiNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Tiejun LiuNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Weibin ChenNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China.
Wenqiang LiThe First People's Hospital of Zigong City, Zigong City, Sichuan Province, China.
Jingshan BaiDepartment of Respiratory and Critical Care Medicine, Xuanwu Hospital, Xiongan, China.
Aishuang FuNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China. maxfas@163.com.
Yanlei GeNorth China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China. 495732196@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A clinical case‒control study was conducted to identify risk factors for severe COVID-19 and to develop a predictive risk model to provide a reference for the dynamic assessment of the severity of disease in COVID-19 patients. A total of 410 patients with COVID-19 were included in the study, of whom 132 had severe or critical cases. The clinical data of the patients were collected, and the variables were subsequently screened via LASSO regression analysis and 10-fold cross-validation. The screened variables were subjected to multifactorial logistic regression analysis to screen out the independent risk factors for patients with severe or critical illnesses, and the independent risk factors were integrated to construct a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA), showing good predictive accuracy. Five variables, including the respiratory rate (R), systolic blood pressure (SBP), plasma albumin (ALB), lactate dehydrogenase (LDH), and C-reactive protein (CRP), were ultimately included to construct a clinical prediction model, with an area under the curve (AUC) of 0.86 (CI 0.82-0.90%). The clinical prediction model constructed in this study using simple clinical indicators can assist in the clinical prediction and identification of patients with heavy or critical COVID-19.

Indexed as

COVID-19AdultAgedBlood PressureCase-Control StudiesC-Reactive ProteinFemaleHumansL-Lactate DehydrogenaseLogistic ModelsMaleMiddle AgedNomogramsRespiratory RateRisk AssessmentRisk FactorsC-Reactive ProteinL-Lactate DehydrogenaseSerum AlbuminCOVID-19NomogramPredictive modelSARS-CoV-2

Identifiers

PMID40898196
PMCPMC12403599

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.